EuroEyes International Eye Clinic Limited (HKG:1846)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.650
0.00 (0.00%)
Apr 24, 2026, 1:42 PM HKT

HKG:1846 Income Statement

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
796.04715.68714.29610.29632.93
Revenue Growth (YoY)
11.23%0.19%17.04%-3.58%33.58%
Cost of Revenue
471.71429.09378.77339.45320.39
Gross Profit
324.33286.59335.52270.84312.55
Selling, General & Admin
209.32196.48162.22134.01122.75
Other Operating Expenses
-1.66-3.94-4.86-3.95-1.87
Operating Expenses
207.82192.88157.58130.1120.99
Operating Income
116.5193.72177.94140.75191.56
Interest Expense
-9.27-10.04-9.7-7.12-7.49
Interest & Investment Income
13.3623.5719.331.140.14
Currency Exchange Gain (Loss)
-14.062.9-8.095.7712.74
Other Non Operating Income (Expenses)
-2.21-5.75-4.44-3.62-0.97
EBT Excluding Unusual Items
104.32104.4175.04136.92195.97
Merger & Restructuring Charges
----3.29-
Gain (Loss) on Sale of Assets
2.67-1.08-0.380.21-0.29
Other Unusual Items
-4.5523.1515.96-4.85-
Pretax Income
102.44126.47190.61128.98195.67
Income Tax Expense
45.8142.1157.3645.4663.29
Earnings From Continuing Operations
56.6384.36133.2583.52132.38
Minority Interest in Earnings
-2.18-2.07-2.015.951.18
Net Income
54.4582.29131.2489.47133.56
Net Income to Common
54.4582.29131.2489.47133.56
Net Income Growth
-33.83%-37.30%46.69%-33.01%103.66%
Shares Outstanding (Basic)
320330332332328
Shares Outstanding (Diluted)
320330332332329
Shares Change (YoY)
-3.17%-0.60%-0.01%0.95%-12.38%
EPS (Basic)
0.170.250.400.270.41
EPS (Diluted)
0.170.250.400.270.41
EPS Growth
-31.66%-36.93%46.70%-33.64%132.43%
Free Cash Flow
-117.41102.94152.74229.28
Free Cash Flow Per Share
-0.360.310.460.70
Dividend Per Share
0.0440.0650.1000.0630.099
Dividend Growth
-31.73%-35.40%59.59%-36.91%232.40%
Gross Margin
40.74%40.04%46.97%44.38%49.38%
Operating Margin
14.64%13.10%24.91%23.06%30.26%
Profit Margin
6.84%11.50%18.37%14.66%21.10%
Free Cash Flow Margin
-16.41%14.41%25.03%36.23%
EBITDA
163.64140.85215.12174.54220.08
EBITDA Margin
20.56%19.68%30.12%28.60%34.77%
D&A For EBITDA
47.1347.1337.1833.7928.52
EBIT
116.5193.72177.94140.75191.56
EBIT Margin
14.64%13.10%24.91%23.06%30.26%
Effective Tax Rate
44.71%33.30%30.09%35.25%32.34%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.